MRSNMersana Therapeutics Inc
MRSN
Mersana Therapeutics Inc2,876
Mkt Cap
$144.96MVolume
9,301.0052W High
$40.2552W Low
$5.21PE Ratio
-2.06MRSN Fundamentals
Price
$29.02Prev Close
$29.00Open
$29.0150D MA
$19.86Beta
1.87Avg. Volume
245,811.47EPS (Annual)
-$14.12P/B
-2.43Rev/Employee
$397,029.41Halper Sadeh LLC Encourages UDMY, ALEX, UBFO, MRSN Shareholders to Contact the Firm to Discuss Their Rights
Halper Sadeh LLC Encourages UDMY, ALEX, UBFO, MRSN Shareholders to Contact the Firm to Discuss Their Rights Halper Sadeh LLC Encourages UDMY, ALEX, UBFO, MRSN Shareholders to Contact the Firm to...
PR Newswire·17h ago
Halper Sadeh LLC Encourages MRSN, CDTX, RYI Shareholders to Contact the Firm to Discuss Their Rights
Halper Sadeh LLC Encourages MRSN, CDTX, RYI Shareholders to Contact the Firm to Discuss Their Rights Halper Sadeh LLC Encourages MRSN, CDTX, RYI Shareholders to Contact the Firm to Discuss Their...
PR Newswire·7d ago
Shareholder Alert: The Ademi Firm continues to investigate whether Mersana Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders
Shareholder Alert: The Ademi Firm continues to investigate whether Mersana Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders Shareholder Alert: The Ademi Firm continues to...
PR Newswire·8d ago
Luminus Management LLC Sells 989,314 Shares of Mersana Therapeutics, Inc. $MRSN
Luminus Management LLC trimmed its stake in shares of Mersana Therapeutics, Inc. (NASDAQ:MRSN - Free Report) by 95.2% in the third quarter, according to the company in its most recent filing with the...
MarketBeat·8d ago
683 Capital Management LLC Boosts Stock Position in Mersana Therapeutics, Inc. $MRSN
683 Capital Management LLC lifted its stake in shares of Mersana Therapeutics, Inc. (NASDAQ:MRSN - Free Report) by 20.6% in the second quarter, according to the company in its most recent filing with...
MarketBeat·11d ago
Mersana Therapeutics Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Mersana Therapeutics, Inc. - MRSN
Mersana Therapeutics Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Mersana Therapeutics, Inc...
PR Newswire·12d ago
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--SMLR, MRSN, CDTX, and RYI
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--SMLR, MRSN, CDTX, and RYI $HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--SMLR...
PR Newswire·16d ago
Mersana Therapeutics, Inc. (NASDAQ:MRSN) Given Consensus Recommendation of "Reduce" by Brokerages
Mersana Therapeutics, Inc. (NASDAQ:MRSN - Get Free Report) has earned a consensus recommendation of "Reduce" from the eight brokerages that are presently covering the company, Marketbeat Ratings...
MarketBeat·22d ago
Halper Sadeh LLC Encourages SEMR, EXAS, MRSN Shareholders to Contact the Firm to Discuss Their Rights
Halper Sadeh LLC Encourages SEMR, EXAS, MRSN Shareholders to Contact the Firm to Discuss Their Rights Halper Sadeh LLC Encourages SEMR, EXAS, MRSN Shareholders to Contact the Firm to Discuss Their...
PR Newswire·26d ago
HAPPY THANKSGIVING AND INVESTOR ALERT: The M&A Class Action Firm Continues to Investigate the Merger - EXAS, SEE, CDTX, and MRSN
HAPPY THANKSGIVING AND INVESTOR ALERT: The M&A Class Action Firm Continues to Investigate the Merger - EXAS, SEE, CDTX, and MRSN HAPPY THANKSGIVING AND INVESTOR ALERT: The M&A Class Action Firm...
PR Newswire·27d ago
<
1
2
...
>